期刊文献+

骨髓活检组织印片在全血细胞减少性疾病诊断中的应用 被引量:2

Application of biopsy bone marrow imprint in diagnosis of paneytopenia
下载PDF
导出
摘要 目的探讨骨髓活检组织印片在全血细胞减少诊断中的应用价值。方法分析 5 6例全血细胞减少患者的骨髓活检组织印片、骨髓活检组织切片和骨髓穿刺涂片的诊断结果。结果骨髓活检组织印片及切片的诊断符合率高于骨髓穿刺涂片 ,尤其在诊断原发性骨髓纤维化 (骨纤 )、再生障碍性贫血 (再障 )、骨髓转移癌时 ,其符合率明显高于骨髓穿刺涂片检查 .骨髓活检组织印片及切片两者之间的诊断符合率无明显差异 ,但骨髓活检组织印片观察细胞细微结构较切片好 ,且操作简单、确诊及时。 Objectives To investigate the role of biopsy bone marrow imprint in diagnosis of paneytopenia.Methods Fifty six cases of diagnosed paneytopenia were selected. Their biopsy bone marrow imprint, biopsy marrow sections and marrow smear were analysed and compared with one another.Results It was showed that the diagnostic accuracy of bone marrow imprint and section were both significantly higher than that of bone marrow smear, especially in the patients with myelofibrosis, aplastic anemia and metastatic carcinoma. There was no significant difference between bone marrow imprint and biopsy section. However, bone marrow imprint offered a better cellular structure compared with biopsy section. It was also simpler and more convenient.Conclusions Bone marrow imprint was valuable to diagnosis of paneytopenia.
出处 《临床误诊误治》 2004年第3期161-162,共2页 Clinical Misdiagnosis & Mistherapy
关键词 骨髓活检组织印片 全血细胞减少性疾病 诊断 骨髓穿刺 血液学检查 Bone marrow Biopsy Paneytopenia Diagnosis
  • 相关文献

参考文献3

  • 1林果为 王宝珍 陈灏珠 主编.造血细胞疾病[A].陈灏珠,主编.实用内科学,下册:第11版[C].北京:人民卫生出版社,2001.2088-2127.
  • 2陈辉树 钱林生 李华珠 等.骨髓增生不均对骨髓活检与临床的影响[J].临床血液学杂志,1995,8(1):27-29.
  • 3戚仁铎 主编.诊断学:第4版[M].北京:人民卫生出版社,1997.326.

共引文献8

同被引文献22

  • 1陈辉树,杜心垿.我国血液病理学研究50年的回顾[J].中华病理学杂志,2005,34(9):553-555. 被引量:6
  • 2刘恩彬,陈辉树.淋巴瘤侵犯骨髓的骨髓活检病理学诊断研究进展[J].癌症,2005,24(11):1416-1420. 被引量:8
  • 3于晓明,唐桂华,李秀娟.HAG方案治疗低增生性及老年性急性髓细胞白血病疗效观察[J].中国医药,2006,1(7):394-395. 被引量:9
  • 4郭宏谋.低增生性急性白血病10例诊治分析[J].临床误诊误治,2007,20(1):84-84. 被引量:4
  • 5陆再英,钟南山.内科学[M].北京:人民卫生出版社,2009:493.
  • 6Jaffe E S, Harris N L, Stein H, et al. World Health Organization classification of tumors. Pathology and genetics of tumor of haematopoietic and lymphoid tissues [ M ]. Lyon: IARC Press, 2001:15-154.
  • 7单渊东.低增生性急性白血病[M]//武永吉.血液系疾病诊断与诊断评析.上海:上海科学技术出版社,2004:63-64.
  • 8Bennett J M, Orazi A. Diagnostic criteria to distinguish hy- pocellular acute myeloid leukemia from myelodysplastic syn-dromes and aplastic anemia: recommendations for a stand- ardized approach[ J]. haematologica, 2009,94(2) :264-268.
  • 9Vardiman J W, Harris N L, Brunning R D. The World Health Organization(WHO) classification of the myeloid ne- oplasms [ J ]. blood, 2002,100 (7) :2292-2302.
  • 10von Bubnoff N, Gorantla S P, Engh R A, et al. The low fre- quency of clinical resistance to PDGFR inhibitors in myeloid neoplasms with abnormalities of PDGFRA might be related to the limited repertoire of possible PDGFRA kinase domain mutations in vitro [ J ]. Oncogene, 2011,30 ( 8 ) :933-943.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部